YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Project MATLINK: Development and Evaluation of a Screening, Brief Intervention, & Referral to Treatment (SBIRT) Program for Opioid Dependent Prisoners and Probationers Transitioning to the Community

Not Applicable

Active, not recruiting

Conditions: HIV Infections
Opioid-use Disorder
Tuberculosis
Hepatitis B
Depression
Syphilis
Hepatitis C

Interventions: Behavioral: SBIRT

First Posted Date: 2021-07-01

Last Posted Date: 2023-11-03

Lead Sponsor: Yale University

Target Recruit Count: 835

Registration Number: NCT04947475

Locations: 🇰🇬
AIDS Foundation East-West, Bishkek, Kyrgyzstan
🇲🇩
AFI - Act for Involvement, Chisinau, Moldova, Republic of
🇺🇦
Ukrainian Institute for Public Health Policy, Kyiv, Ukraine

Sympathetic Activation in Obesity

Not Applicable

Completed

Conditions: Obesity
Healthy

Interventions: Diagnostic Test: PET Scan
Dietary Supplement: Mixed Meal Test
Diagnostic Test: Muscle sympathetic nerve activity (MSNA)
Diagnostic Test: Oral Glucose Tolerance Test
Other: Body Composition, Percent Body Fat & Percent Body Water (Tanita scale)
Diagnostic Test: CT Scan
Other: Body Composition, Percent Body Fat & Percent Body Water (DXA Scan)

First Posted Date: 2021-07-01

Last Posted Date: 2024-02-16

Lead Sponsor: Yale University

Target Recruit Count: 5

Registration Number: NCT04946552

Locations: 🇺🇸
Church Street Research Unit, New Haven, Connecticut, United States

Ketamine for the Treatment of Depression in Parkinson's Disease

Phase 2

Recruiting

Conditions: Parkinson's Disease
Depression

Interventions: Other: Placebo - Saline Infusion
Drug: Ketamine Infusion

First Posted Date: 2021-06-29

Last Posted Date: 2024-11-12

Lead Sponsor: Yale University

Target Recruit Count: 56

Registration Number: NCT04944017

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Transcranial Magnetic Stimulation (TMS) Study for Adults With Autism Spectrum Disorder (ASD)

Not Applicable

Recruiting

Conditions: Autism Spectrum Disorder

Interventions: Behavioral: Transcranial Magnetic Stimulation (TMS)

First Posted Date: 2021-06-23

Last Posted Date: 2024-04-25

Lead Sponsor: Yale University

Target Recruit Count: 60

Registration Number: NCT04936009

Locations: 🇺🇸
Yale University Child Study Center, New Haven, Connecticut, United States

Implementing and Evaluating a Social-Emotional Learning Program for Refugee Children During the COVID-19 Pandemic

Not Applicable

Completed

Conditions: Social Emotional Wellness

Interventions: Behavioral: EMPOWER

First Posted Date: 2021-06-18

Last Posted Date: 2023-11-30

Lead Sponsor: Yale University

Target Recruit Count: 31

Registration Number: NCT04931888

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Integrating Addiction Treatment and HIV Services Into Primary Care Clinics in Ukraine

Not Applicable

Completed

Conditions: Opioid-use Disorder
Hiv

Interventions: Other: Integration of HIV and PWID services

First Posted Date: 2021-06-15

Last Posted Date: 2024-07-10

Lead Sponsor: Yale University

Target Recruit Count: 1458

Registration Number: NCT04927091

Locations: 🇺🇦
European Institute for Public Health Policy, Kyiv, Ukraine

Catheter-Related Early Thromboprophylaxis with Enoxaparin Studies

Phase 2

Recruiting

Conditions: Deep Venous Thrombosis

Interventions: Drug: Enoxaparin

First Posted Date: 2021-06-11

Last Posted Date: 2025-01-03

Lead Sponsor: Yale University

Target Recruit Count: 258

Registration Number: NCT04924322

Locations: 🇺🇸
Children's of Alabama, Birmingham, Alabama, United States
🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States
🇺🇸
Yale-New Haven Children's Hospital, New Haven, Connecticut, United States

and more 16 locations

Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men

Phase 1

Withdrawn

Conditions: Hypertension
Hyperlipidemias

Interventions: Drug: Atorvastatin
Other: placebo

First Posted Date: 2021-06-10

Last Posted Date: 2022-11-03

Lead Sponsor: Yale University

Registration Number: NCT04922424

Locations: 🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States

In Vivo Study of THC-induced Immune-genome Changes at Single Cell Solution in HIV-infected Humans

Phase 1

Recruiting

Conditions: Healthy
HIV Infections

Interventions: Drug: Active Delta-9-THC

First Posted Date: 2021-06-10

Last Posted Date: 2023-12-05

Lead Sponsor: Yale University

Target Recruit Count: 40

Registration Number: NCT04920539

Locations: 🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States

Developing a Chatbot to Promote HIV Testing

Not Applicable

Not yet recruiting

Conditions: HIV Infections

Interventions: Behavioral: Chatbot messages
Behavioral: Attention-matched educational materials

First Posted Date: 2021-06-02

Last Posted Date: 2024-04-19

Lead Sponsor: Yale University

Target Recruit Count: 80

Registration Number: NCT04910984

Locations: 🇲🇾
University of Malaya, Kuala Lumpur, Jalan Pantai Baharu, Malaysia

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy